X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Enoxaparin is a low-molecular-weight heparin given as a thrombosis injection under the skin — after surgery, with a plaster cast or bed rest, to treat thrombosis and pulmonary embolism, and during pregnancy. Many people inject it themselves after a short introduction. What matters is a clean technique and reliably recognising signs of bleeding and the rare but serious heparin allergy (HIT).
See more detail.gif)
Reminders, an injection-site log and a record of your observations — free in the brite app.
| Property | Details |
|---|---|
| Active ingredient | Enoxaparin sodium |
| ATC code | B01AB05 |
| Drug class | Low-molecular-weight heparin (LMWH), an anticoagulant; obtained from the intestinal lining of pigs |
| Dosage forms | Pre-filled syringes for injection under the skin, according to the SmPC of the original product from 2,000 to 10,000 IU (20 to 100 mg); multi-dose vials for hospital and dialysis use; several biosimilars as well |
| Half-life | About 5 hours after a single dose, up to about 7 hours after repeated doses; longer with impaired kidney function |
| Maximum daily dose | No fixed upper limit; for prevention usually 2,000 or 4,000 IU once a day, for treatment according to body weight. Your dose is set by the practice |
| Onset of effect | Maximum effect 3 to 5 hours after the injection; a stable level from the second day of treatment |
| Prescription status | Prescription-only medicine |
| Notable feature | Not interchangeable unit for unit with other low-molecular-weight heparins; contraindicated in heparin allergy (HIT); according to the SmPC, platelets are monitored |
Blood clotting is a chain of proteins that activate each other — at the end there is a firm plug of fibrin. The body has a natural counterpart to this, antithrombin. Enoxaparin strengthens this counterpart and thereby inhibits above all clotting factor Xa and, to a lesser extent, thrombin (factor IIa).¹ As a result, fewer new clots form and existing ones stop growing. Enoxaparin cannot dissolve a clot — the body does that itself over time.
Why you are given enoxaparin depends on the situation. Usually the aim is to prevent or treat thrombosis or pulmonary embolism. The article on the condition explains causes, symptoms and diagnosis; this article is about the injection itself and what to bear in mind with it in everyday life.
The dose is given in International Units (IU); many packs also state the amount in milligrams: 100 IU correspond to 1 mg. The following information reflects the SmPC and is not a dosing instruction. Which dose you inject and for how long is set by the treating practice or hospital.¹
The German S3 guideline on thrombosis prophylaxis stresses that the type and duration of prevention depend on individual risk — on the type of surgery or illness and on personal factors such as previous thromboses, cancer, excess weight or age.² This is why the duration can differ between two people having the same operation. Ask until what date you should inject, and make a note of it.
This is the practical section of this article. Most people learn to inject in a few minutes at the hospital or practice. The following steps summarise the technique from the SmPC; what counts is the patient leaflet in your pack, because syringes and safety systems differ between manufacturers.¹
Log injection sites and times so that you never inject into the same spot twice and no dose is missed.
Most side effects affect the injection site or follow directly from the anticoagulation. According to the SmPC, bleeding, a drop or rise in platelets and raised liver values are among the most frequent findings.¹
This is the most important section of this article. Used correctly, enoxaparin is well tolerated. However, you should know two complications so well that you recognise them straight away: serious bleeding and heparin-induced thrombocytopenia (HIT).
With any anticoagulation, you bleed more easily and for longer. A bruise on the tummy, slightly longer bleeding after shaving or occasional bleeding gums are usually harmless. Bleeding that comes from inside or does not stop is a different matter:
In heparin-induced thrombocytopenia type II, the immune system forms antibodies against a complex of heparin and a protein from the platelets. The platelets are activated and used up — paradoxically, the danger is not bleeding but new clots in veins and arteries. With low-molecular-weight heparins such as enoxaparin, this is less common than with unfractionated heparin, but it is possible.¹
If you have ever had HIT, you should state this in every medication plan and at every hospital admission: according to the SmPC, enoxaparin must not be used within 100 days afterwards or for as long as antibodies can be detected.¹ How to record such information permanently is explained in the guide recognising drug allergies.
Enoxaparin is not broken down by the typical liver enzymes. Interactions therefore arise almost exclusively where other medicines also affect the stopping of bleeding — or raise the potassium level.¹
| Combination | Consequence | What to do |
|---|---|---|
| Anti-inflammatory painkillers such as ibuprofen, diclofenac, naproxen; aspirin at pain-relief doses | Considerably increased risk of bleeding, especially in the stomach and bowel | According to the SmPC, stop them if possible; for pain, discuss alternatives such as paracetamol |
| Other anticoagulants such as phenprocoumon, rivaroxaban or apixaban | Combined anticoagulation | Only during a planned switch, following a medical schedule |
| Antiplatelet medicines such as low-dose aspirin or clopidogrel | More bleeding | Only after medical consideration, e.g. after a heart attack or stent |
| Systemic cortisone such as prednisolone or dexamethasone | Higher risk of bleeding, especially in the stomach | With caution, consider stomach protection |
| Potassium-raising medicines such as ramipril and other ACE inhibitors, sartans, spironolactone, potassium supplements | Raised potassium level, especially with diabetes or kidney impairment | Have potassium checked |
| Herbal remedies and food supplements that affect clotting, such as high-dose fish oil or ginkgo | Possibly more bleeding | Mention them at your practice or pharmacy |
The most common everyday trap is the painkiller after surgery. If you inject enoxaparin after knee or hip surgery and also take ibuprofen or diclofenac for the pain, you increase the risk of bleeding — and after spinal or epidural anaesthesia also the risk of bleeding around the spinal cord.¹ This does not mean that the combination is never prescribed; but it should be a deliberate choice with a clear duration. The second trap is the switch to tablets: when switching to phenprocoumon, enoxaparin is continued until the INR is in the target range, whereas when switching to modern anticoagulants it is stopped at the time of the first tablet.¹ If you get confused here, you either inject twice or end up with a gap. An interaction check across your whole list, including over-the-counter painkillers and food supplements, brings clarity.
Alcohol is not listed as an interaction in the SmPC. However, larger amounts increase the risk of falls and injuries and irritate the stomach lining — both unfavourable while on anticoagulation. More under medications and alcohol.
Tablets are now also available to treat thrombosis or pulmonary embolism. Alongside low-molecular-weight heparins, the German S2k guideline on venous thrombosis and pulmonary embolism describes above all the direct oral anticoagulants (DOACs) as options; which medicine is suitable depends on factors such as kidney function, cancer, pregnancy and other medicines.³
| Medicine | Form | Typical use | Typical drawback |
|---|---|---|---|
| Enoxaparin and other LMWHs | Injection, once or twice a day | Prophylaxis after surgery and with a plaster cast, pregnancy, start of treatment, cancer | Daily injection, bruises, risk of HIT |
| Rivaroxaban, apixaban, edoxaban, dabigatran | Tablet | Treatment of thrombosis and pulmonary embolism, prophylaxis after hip or knee replacement (depending on the licence) | Not during pregnancy and breastfeeding; kidney function must be taken into account |
| Phenprocoumon | Tablet | Long-term treatment, e.g. with a mechanical heart valve | Regular INR checks, many interactions |
Alongside the original product, there are several biosimilars containing the active ingredient enoxaparin. They are comparable in quality and effect; background in the guide understanding biosimilars. One particular point from the SmPC is important: enoxaparin must not be exchanged unit for unit with other low-molecular-weight heparins such as dalteparin, tinzaparin or nadroparin, because these active ingredients differ in their units and dosing.¹ If a different name suddenly appears on the pack after you leave hospital, ask at the pharmacy whether it is the same active ingredient at the same dose.
Probably not. Bruises at the injection site are among the most common side effects and occur even with good technique. They become less frequent if you change the sites consistently, inject slowly, leave the air bubble in the syringe and do not rub afterwards. You should pay attention if bruises also appear where you have not injected, if they become unusually large or if an injection site becomes increasingly painful, discoloured or hard. Then a doctor needs to take a look.
Many people feel that way, and it is no reason to go without prophylaxis. It helps to give the first injection yourself under guidance at the hospital or practice. The needles are very short and thin, and many people find the prick less bad than expected. If it still does not work out, relatives can learn to do it or a home care service can take over. Also ask whether a tablet is an alternative in your situation — that is possible after some operations.
That is decided by the hospital or practice and depends on the procedure, your mobility and your personal risk. After major orthopaedic surgery, the SmPC provides for extended prophylaxis of up to five weeks. Do not stop on your own just because you can walk a few steps again — the risk of thrombosis is increased especially in the first weeks after a joint replacement. Note down the end date from your discharge letter and clarify any open questions at your follow-up appointment.
First of all: no double dose. With once-daily prophylaxis, a single missed injection is usually not an emergency, but it should be discussed promptly with your practice or pharmacy — they will tell you whether to make it up or carry on at the usual time. Over the following days, watch for warning signs of thrombosis such as a swollen, painful leg on one side or sudden breathlessness. A fixed time with a reminder prevents it from happening again.
The interaction check reviews your whole list for bleeding and potassium risks.
Daily reminders, an injection-site log, your end date in view and an interaction check in one place. Free.
Create medication plan